Schonfeld Strategic Advisors LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager
Schonfeld Strategic Advisors LLC
Reporting Manager
Schonfeld Strategic Advisors LLC
Security
Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share
Symbol
RVPH
Shares outstanding
46,628,191 shares
Disclosed Ownership
1,314,915 shares
Ownership
2.8%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:16:26 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Schonfeld Strategic Advisors LLC disclosed 2.8% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH) on 31 Dec 2024."

Quick Takeaways

  • Schonfeld Strategic Advisors LLC filed SCHEDULE 13G/A for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH).
  • Disclosed ownership: 2.8%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:16.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Schonfeld Strategic Advisors LLC 2.8% 1,314,915 1,314,915 0 /s/ Mark H. Peckman Mark H. Peckman/General Counsel and Chief Compliance Officer

Sponsored